- Home
- EXEL vs CHSCO Comparison
EXEL vs CHSCO Comparison
Compare EXEL & CHSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- CHSCO
- Stock Information
- Founded
- EXEL 1994
- CHSCO N/A
- Country
- EXEL United States
- CHSCO United States
- Employees
- EXEL N/A
- CHSCO N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- CHSCO Farming/Seeds/Milling
- Sector
- EXEL Health Care
- CHSCO Industrials
- Exchange
- EXEL Nasdaq
- CHSCO Nasdaq
- Market Cap
- EXEL 9.8B
- CHSCO N/A
- IPO Year
- EXEL 2000
- CHSCO N/A
- Fundamental
- Price
- EXEL $36.17
- CHSCO $26.30
- Analyst Decision
- EXEL Buy
- CHSCO
- Analyst Count
- EXEL 18
- CHSCO 0
- Target Price
- EXEL $37.59
- CHSCO N/A
- AVG Volume (30 Days)
- EXEL 2.2M
- CHSCO N/A
- Earning Date
- EXEL 05-13-2025
- CHSCO N/A
- Dividend Yield
- EXEL N/A
- CHSCO N/A
- EPS Growth
- EXEL 170.77
- CHSCO N/A
- EPS
- EXEL 1.76
- CHSCO N/A
- Revenue
- EXEL $2,168,701,000.00
- CHSCO N/A
- Revenue This Year
- EXEL $5.78
- CHSCO N/A
- Revenue Next Year
- EXEL $10.94
- CHSCO N/A
- P/E Ratio
- EXEL $20.64
- CHSCO N/A
- Revenue Growth
- EXEL 18.50
- CHSCO N/A
- 52 Week Low
- EXEL $20.14
- CHSCO N/A
- 52 Week High
- EXEL $40.26
- CHSCO N/A
- Technical
- Relative Strength Index (RSI)
- EXEL 43.89
- CHSCO 54.54
- Support Level
- EXEL $34.90
- CHSCO $26.13
- Resistance Level
- EXEL $40.26
- CHSCO $26.44
- Average True Range (ATR)
- EXEL 1.21
- CHSCO 0.19
- MACD
- EXEL -0.19
- CHSCO 0.02
- Stochastic Oscillator
- EXEL 23.69
- CHSCO 53.19
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About CHSCO CHS Inc. Class B Cumulative Redeemable Preferred Stock
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).